Chimeric Antigen Receptor T Cells Targeting CD19 and Ibrutinib for Chronic Lymphocytic Leukemia
Hemasphere
.
2019 Feb 8;3(2):e174.
doi: 10.1097/HS9.0000000000000174.
eCollection 2019 Apr.
Authors
Julio Delgado
1
2
,
Miguel Caballero-Baños
3
,
Valentín Ortiz-Maldonado
1
,
Maria Castellà
1
,
Laura Magnano
2
4
,
Manel Juan
3
,
Álvaro Urbano-Ispizua
1
Affiliations
1
Department of Hematology, Hospital Clínic, IDIBAPS, Barcelona, Spain.
2
CIBERONC, Barcelona, Spain.
3
Department of Immunology, Hospital Clínic, IDIBAPS, Barcelona, Spain.
4
Hematopathology Unit, Hospital Clínic, IDIBAPS, Barcelona, Spain.
PMID:
31723815
PMCID:
PMC6746038
DOI:
10.1097/HS9.0000000000000174
No abstract available
Publication types
Case Reports